BCRF unveils a $100M fund, awarding its first investment to AI mammography company Clairity Inc.
Key Details
- 1Breast Cancer Research Foundation (BCRF) launches a new $100M venture fund to accelerate innovation.
- 2Initial $23 million raised, $11 million from donors Karen and Rob Hale.
- 3First investment goes to Clairity Inc., founded by radiologist Connie Lehman.
- 4Clairity Breast uses AI to analyze mammograms and predict 5-year breast cancer risk.
- 5Clairity Breast was the first AI-powered breast cancer risk prediction tool to win FDA De Novo Authorization.
- 6The solution is now part of national guidelines for breast cancer risk assessment.
Why It Matters
This marks one of the largest targeted investments into AI-driven breast imaging, backing scalable risk prediction in routine mammography. The fund's support could accelerate the adoption of AI-powered tools in radiology, helping address early detection and access disparities.
Source
Radiology Business
Related News
•Radiology Business
a2z Radiology AI’s Abdo-Triage Cleared for Expanded CT Findings
FDA has cleared a2z Radiology AI's Abdo-Triage tool to triage 10 additional findings on abdomen-pelvis CT scans.
•Radiology Business
Epsilon Health Launches With $28M to Build 'AI-Native' Imaging Practice
Epsilon Health has exited stealth mode, raising nearly $28M to launch an 'AI-native' radiology imaging group aimed at addressing the U.S. radiologist shortage.
•Radiology Business
Harrison.ai Restructures and Launches U.S. AI-Enabled Teleradiology Venture
Harrison.ai lays off staff amid major restructuring and launches Frontier Radiology, an AI-powered U.S. teleradiology business.